Rheumatologe

Blog von Dr. med. Lothar M. Kirsch / 祁建德 // Poetry / Travels / Languages / Rheumatic Diseases / Tea

Seiten / Pages

▼
Showing posts with label Filgotinib. Show all posts
Showing posts with label Filgotinib. Show all posts
Tuesday, May 26, 2020

Januskinase-Inhibitoren

›
Januskinase-Inhibitoren werden seit einigen Jahren in der Rheumatologie angewendet. Ich hatte mit bereits vor etwa 10 Jahren näher m...
Friday, June 16, 2017

Filgotinib at the 2017 EULAR Annual Meeting in Madrid

›
Filgotinib (GLPG0634, GS-6034) is an oral, selective JAK1 inhibitor, which is studied in combination with methotrexate (MTX) or a...
Wednesday, May 31, 2017

High Hopes and Aspirations or how ASP015K / Peficitinib brings back the Small Molecule Hype

›
ASP015K, now called peficitinib is an oral Janus kinase (JAK) inhibitor with selectivity for JAK1/3, developed by Astellas Pharma...
Monday, November 23, 2015

Filgotinib at the ACR 2015 Meeting in San Francisco

›
There have been seven publications on Filgotinib at the ACR 2015 Annual Meeting in San Francisco. Filgotinib (already known as: GLPG0634)...
Monday, July 14, 2014

GLPG0634 at the EULAR 2014 in Paris

›
GLPG0634 is selective inhibitor of Janus kinase 1 (JAK-1) and I have been quite thrilled by this new drug since the ACR 2012 in Washingto...
›
Home
View web version

Über mich / About myself / 自己的介绍

Rheumatologe
View my complete profile
Powered by Blogger.